Johnson & Johnson JNJ 164.51 Johnson & Johnson

Home
⇒ 
Stock List ⇒ Johnson & Johnson
Range:143.13-168.85Vol Avg:6548429Last Div:4.96Changes:0.95
Beta:0.52Cap:388.67BCurrency:USDExchange:NYSE
Sector:HealthcareIPO:Sat Jan 02 1943Empoloyees:131900
CUSIP:478160104CIK:0000200406ISIN:US4781601046Country:US
CEO:Mr. Joaquin DuatoWebsite:https://www.jnj.com
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Stock Details

Positive 0.12

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024

https://www.businesswire.com/news/home/20241015885690/en/Johnson-Johnson-Announces-Quarterly-Dividend-for-Fourth-Quarter-2024/·Tue Oct 15 2024
Positive 0.53

J&J lifts profit and sales forecasts, beats Wall Street expectations

https://www.reuters.com/business/healthcare-pharmaceuticals/jj-lifts-profit-sales-forecasts-beats-wall-street-expectations-2024-10-15/·Tue Oct 15 2024
Positive 0.19

Johnson & Johnson Reports Q3 2024 Results

https://www.businesswire.com/news/home/20241014447723/en/Johnson-Johnson-Reports-Q3-2024-Results/·Tue Oct 15 2024
Контент, наданий на цьому сайті, призначений лише для інформаційних цілей і не є фінансовою, інвестиційною чи професійною порадою. Ми не є зареєстрованими інвестиційними радниками або фінансовими планерами, і ми не надаємо рекомендацій чи порад щодо купівлі, продажу або утримання будь-яких конкретних акцій або цінних паперів. Будь-які інвестиційні рішення слід приймати на основі власних досліджень та консультацій з кваліфікованим фінансовим фахівцем. Ми не несемо відповідальності за будь-які фінансові втрати чи збитки, понесені внаслідок покладання на інформацію, надану на цьому сайті. Будь ласка, інвестуйте відповідально та звертайтесь за професійною порадою, коли це потрібно.
DMCA.com Protection StatusСтворено StackThrow